Skip to main content
. 2024 Aug 30;14:20155. doi: 10.1038/s41598-024-71211-x

Fig. 2.

Fig. 2

The altered pathways and biomarkers in metabolomics. (A) The enrichment analysis of differential metabolism revealed various metabolic changes between MNA NB and non-MNA NB. (B) The pathway analysis revealed significant abnormalities in the pathways between MNA NB and non-MNA NB. The representative metabolic biomarker ROC curve and boxplot of (C) elaidic carnitine and (D) C16 Sphinganine.